| Deborah S Haas, | |
|
1700 W Paradise Dr, West Bend, WI 53095-9795 | |
| (262) 334-3451 | |
| Not Available |
| Full Name | Deborah S Haas |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 23 Years |
| Location | 1700 W Paradise Dr, West Bend, Wisconsin |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043392871 | NPI | - | NPPES |
| 1042 | Other | INTERNAL ID-MOTOR VEHICLE ID |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 46882 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Horizon Homecare And Hospice | Milwaukee, WI | Hospice |
| St Josephs Community Hospital West Bend | West bend, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Froedtert Andthe Medical College Of Wisconsin Community Physicians Inc | 3678760063 | 1040 |
News Archive
Three years ago, Terry Tuton was laid off from his job as project manager at a large technology firm, leaving him limited insurance coverage at a time when he was suffering from overpowering feelings of hopelessness and depression - and not for the first time in his life.
Results of an independent clinical study conducted by U.S. Army combat support surgeons in Baghdad show that a new medical device used to close a type of surgical wound more quickly is saving lives and limbs of soldiers and civilians.
NeuroDerm, Ltd. announced today that enrollment of patients is ongoing in its second Phase II clinical trial of ND0612, a novel drug formulation for the treatment of Parkinson's disease. ND0612 is a proprietary levodopa/carbidopa liquid formulation under development for continuous subcutaneous administration through a patch pump. It is designed to provide steady levodopa blood levels for the treatment of Parkinson's disease.
Acura Pharmaceuticals, Inc. and King Pharmaceuticals®, Inc. today announced that the U.S. Food and Drug Administration's (FDA) Anesthetic and Life Support Drugs and Drug Safety and Risk Management Committees voted that they do not have enough evidence to support the approval of the New Drug Application (NDA) for Acurox® (oxycodone HCl and niacin) Tablets for the treatment of moderate to severe pain, considering the deterrent effects of niacin as well as the potential deterrent effects of the other features specific to Acurox®.
› Verified 4 days ago
| Entity Name | Froedtert &the Medical College Of Wisconsin Community Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568787448 PECOS PAC ID: 3678760063 Enrollment ID: O20101210000699 |
News Archive
Three years ago, Terry Tuton was laid off from his job as project manager at a large technology firm, leaving him limited insurance coverage at a time when he was suffering from overpowering feelings of hopelessness and depression - and not for the first time in his life.
Results of an independent clinical study conducted by U.S. Army combat support surgeons in Baghdad show that a new medical device used to close a type of surgical wound more quickly is saving lives and limbs of soldiers and civilians.
NeuroDerm, Ltd. announced today that enrollment of patients is ongoing in its second Phase II clinical trial of ND0612, a novel drug formulation for the treatment of Parkinson's disease. ND0612 is a proprietary levodopa/carbidopa liquid formulation under development for continuous subcutaneous administration through a patch pump. It is designed to provide steady levodopa blood levels for the treatment of Parkinson's disease.
Acura Pharmaceuticals, Inc. and King Pharmaceuticals®, Inc. today announced that the U.S. Food and Drug Administration's (FDA) Anesthetic and Life Support Drugs and Drug Safety and Risk Management Committees voted that they do not have enough evidence to support the approval of the New Drug Application (NDA) for Acurox® (oxycodone HCl and niacin) Tablets for the treatment of moderate to severe pain, considering the deterrent effects of niacin as well as the potential deterrent effects of the other features specific to Acurox®.
› Verified 4 days ago
| Entity Name | Horizon Home Care & Hospice Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780687327 PECOS PAC ID: 3476699521 Enrollment ID: O20140224000152 |
News Archive
Three years ago, Terry Tuton was laid off from his job as project manager at a large technology firm, leaving him limited insurance coverage at a time when he was suffering from overpowering feelings of hopelessness and depression - and not for the first time in his life.
Results of an independent clinical study conducted by U.S. Army combat support surgeons in Baghdad show that a new medical device used to close a type of surgical wound more quickly is saving lives and limbs of soldiers and civilians.
NeuroDerm, Ltd. announced today that enrollment of patients is ongoing in its second Phase II clinical trial of ND0612, a novel drug formulation for the treatment of Parkinson's disease. ND0612 is a proprietary levodopa/carbidopa liquid formulation under development for continuous subcutaneous administration through a patch pump. It is designed to provide steady levodopa blood levels for the treatment of Parkinson's disease.
Acura Pharmaceuticals, Inc. and King Pharmaceuticals®, Inc. today announced that the U.S. Food and Drug Administration's (FDA) Anesthetic and Life Support Drugs and Drug Safety and Risk Management Committees voted that they do not have enough evidence to support the approval of the New Drug Application (NDA) for Acurox® (oxycodone HCl and niacin) Tablets for the treatment of moderate to severe pain, considering the deterrent effects of niacin as well as the potential deterrent effects of the other features specific to Acurox®.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Deborah S Haas, 110 Lone Oak Ln, Hartford, WI 53027-2600 Ph: () - | Deborah S Haas, 1700 W Paradise Dr, West Bend, WI 53095-9795 Ph: (262) 334-3451 |
News Archive
Three years ago, Terry Tuton was laid off from his job as project manager at a large technology firm, leaving him limited insurance coverage at a time when he was suffering from overpowering feelings of hopelessness and depression - and not for the first time in his life.
Results of an independent clinical study conducted by U.S. Army combat support surgeons in Baghdad show that a new medical device used to close a type of surgical wound more quickly is saving lives and limbs of soldiers and civilians.
NeuroDerm, Ltd. announced today that enrollment of patients is ongoing in its second Phase II clinical trial of ND0612, a novel drug formulation for the treatment of Parkinson's disease. ND0612 is a proprietary levodopa/carbidopa liquid formulation under development for continuous subcutaneous administration through a patch pump. It is designed to provide steady levodopa blood levels for the treatment of Parkinson's disease.
Acura Pharmaceuticals, Inc. and King Pharmaceuticals®, Inc. today announced that the U.S. Food and Drug Administration's (FDA) Anesthetic and Life Support Drugs and Drug Safety and Risk Management Committees voted that they do not have enough evidence to support the approval of the New Drug Application (NDA) for Acurox® (oxycodone HCl and niacin) Tablets for the treatment of moderate to severe pain, considering the deterrent effects of niacin as well as the potential deterrent effects of the other features specific to Acurox®.
› Verified 4 days ago
Gary L Preisler, Family Medicine Medicare: Medicare Enrolled Practice Location: 1700 W Paradise Dr, West Bend, WI 53095 Phone: 262-334-3451 | |
Bruce G Griswold, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1700 W Paradise Dr, West Bend, WI 53095 Phone: 262-334-3451 | |
Anthony S Guthrie, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1700 W Paradise Dr, West Bend, WI 53095 Phone: 262-334-3451 | |
Daniela Aleman, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1700 W Paradise Dr, West Bend, WI 53095 Phone: 262-334-3451 | |
Kristin Elizabeth Dement, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1700 Paradise Dr, West Bend, WI 53095 Phone: 262-334-3451 | |
Gary M Herdrich, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1700 W Paradise Dr, West Bend, WI 53095 Phone: 262-334-3451 |